TNF and rheumatoid arthritis: In a qualitative synthesis of six RCTs, conducted in places such as the United Kingdom, the United States, Europe, North America, Australia, and Sweden and involving 3772 participants overall, the efficacy and safety of anti-TNF-α agents in patients with RA were assessed (Table 1).